Abstract: 5-Hydroxytryptamine 2 (5-HT2)receptor antagoIchikawa and Meltzer, 1992; Rivest and Marsden,4 .
nists have been shown to interfere with the stimulation of 1992; Sorensen et al., 1992) . The amphetamine ana-_. i_ striatal dopamine synthesis and release produced by the logue 3,4-methylenedioxymethamphetamine (MDMA) , amphetamine analogue 3,4-methylenedioxymethamphehas proved to be a useful tool in the study of this tamine (MDMA). To localize the receptors responsible for interaction. MDMA is a potent releaser of both 5-HI ';i': , i the attenuation of MDMA-induced release, 5-HT2 receptor and dopamine, acutely producing wide-ranging and_ antagonists wereinfused viathe microdialysis probedirectly into the brains of awake, freely moving rats before often dramatic neurochemical effects on both transthe systemic administration of MOMA. Intrastriatat infumitter systems (Johnson et al., 1986 ; Schmidt et al., sions of the selective 5-HT2 antagonist MDL 100,907 pro-1987) . In addition to its effects on release, administra._ duced a concentration-dependent inhibition of MDMA-intion of MDMA to rats produces acute increases in duced dopamine release. Similar results were observed striatal dopamine synthesis (Nash et al., 1990 ) and a with intrastriatal infusions of the 5-HT 2 antagonist amperresultant increase in tissue concentration of the transozicle. In contrast, infusion of MDL 100,907 into the midmitter (Schmidt et al., 1986) . In contrast to the brain region near the dopaminergic cell bodies was withchanges in the dopaminergic system, terminal field '''_ out effect on the MDMA-induced elevation of extracellular concentrations of 5-HT fall precipitously after dopamine in the ipsilateral striatum. Neither antagonist at-MDMA due to a rapid inactivation of tryptophan hytenuated basal transmitter efflux nor the MDMA-stimulated release of [3H]dopamine from striatal slices in vitro droxylase and a simultaneous increase in 5-HT effiux indicating that the in vivo effect of the antagonists was not (Stone et al., 1986 (Stone et al., , 1987 Schmidt and Taylor, 1987) . due to inhibition of the dopamine uptake carrier. Intrastria-
The relationship between the release of 5-HT by tal infusion of tetrodotoxin reduced both basal and MDMA and its effects on the dopaminergic system MDMA-stimulated dopamine efflux and eliminated the cfwas first clarified in a study by Nash et al. (1990) demfect of intrastriatal MDL 100,907. The results indicate that onstrating that the stimulation of dopamine synthesis _, 5-HT2 receptors located in the stdatum augment the reproduced by' MDMA was dependent on 5-HT 2 recep-:
lease of dopamineproduced by high doses of MDMA. Furtor activation. In this study, pretreatment with the ? thermore, these 5-HT_ receptors appear to be located on 5-HT2/_c antagonist ketanserin prevented MDMAnondopaminergic elements of the striatum. Key Words: stimulated dihydroxyphenylalanine (DOPA) accuAmphetamine--Dopamine--3.4-Methylenedioxymethmulation in rats treated with the L-aromatic amino :
amphetamine--Microdialysis--Serotonin 2 receptors. d. Neurochem. 62, 1382 Neurochem. 62, -1389 Neurochem. 62, (1994 . acid decarboxylase inhibitor, NSD 1015. In a subsequent microdialysis study, ketanserin also was shown to attenuate MDMA-induced dopamine release in vivo (Nash, 1990 al., 1989; Sailer et al., 1990 : Gudelsky et al., 1992  MDMA.methylenedioxymethamphetamine; TTX, tetrodotoxin.
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We have used the potent 5-HT2 receptor antagonist as an anchor for each probe. Dental acrylic was used to MDL 100,907 to further extend these findings. MDL secure the probe to the screw and the skull. 100,907 is an a-phenyl-4-piperidinemethanol with a All experiments were performed I day after probe im-300-fold preference for binding at the 5-HT2 receptor plantation. Each implanted rat was tethered in a circular _)f oYer closely related sites such as the 5-HTm, al-12-inch Plexiglas container within a lighted and soundadrenergic, or D2 dopamine receptor (Dudley et al., proof isolation chamber. The chambers were ventilated by means of a small baffled fan. A two-channel liquid swivel 1990). In vivo, MDL 100,907 is a potent antagonist of was used to connect both inlet and outlet lines to the probe. both MDMA-stimulated dopamine synthesis and reFour-channel liquid swivels were used for studies in which lease (Schmidt et al., 1992) . The activity of MDL two probes were simultaneously perfused. A Harvard 22 100,907 against both responses to MDMA specifipump (Harvard Apparatus, Inc., South Natick, MA, caUy implicates the 5-HT 2subtype as the 5-HT recep-U.S.A.) was used to perfuse the probe at 2 ul/min with artifitot responsible for this phenomenon.
In related studcial.CSF containing (mm): NaC1 147.0, KCI 4.0, CaCI2 2.3, ies, MDL 100,907 was also shown to be a potent antagand MgCl2 0.9, pH 6.3 (Kuczenski and Segal, 1989) . The onist of both the amphetamine-induced decrease in dialysate was collected into tubes containing 10 itl of 0.5 M A.:i) dopaminergic neuron firing and of amphetperchloric acid using a refrigerated microfraction collector (Carnegie Medicin, Stockholm, Sweden Microdialysis maintained at 1.0 ml/min using a Waters 600E multisoltT by Microdialysis probes were made based on a concentric vent delivery system (Waters Chromatography Division, design described previously (Schmidt et al., 1992) . Most of Millipore Corporation, Milford, MA, U.S.A.). Detection ystem the experiments were performed using Spectra/Pot hollowwas by means of a Waters 460 electrochemical detector set demfiber membranes to prepare either a 4-mm (striatum) or to a potential of +0.65 V. Individual components in the thesis 2-mm (nigra) length of sealed dialysis tubing at the tip of the samples were integrated and quantitated by comparison to :ecepprobe. The last set of experiments involving tetrodotoxin external standards using Waters Baseline 810 chromatogra-:h the (TTX) infusions used probes made with AN.69-HOSPAL phy software. No corrections tbr recovery were made. )MAme:::branes (CGH Medical Inc., Lakewood, CO, U.S.A.).
Calculations. Dopamine effiux for each animal was conaccu-
The larger diameter of these fibers required substituting 25-verted to the percentage of basal release using the first 1 h of ,_mino gauge stainless steel tubing (Small Parts, Inc., Miami Lakes, collection to calculate a mean basal value. The percent basal ;ubse-FL, U.S.A.) for the 26-gauge tubing used previously, release at each time point was then averaged for all animals All procedures were in accordance with the NIH Guide within a treatment group. The data are presented as the hown for the Care and Use of Laboratorv Animals and were aptse in . meanpercent basalrelease + SEM. Totalrelease overthe proved by the in-house animal care committee. Probes were first 3 h after MDMA administration was calculated from implanted stereotaxically in the right hemisphere of the area under the curve (AUC_so) for each animal after Sprague-Dawley rats (250-300 g) under pentobarbital anessubtraction of the basal release. The results were averaged thesia. Coordinates relative to bregma were I (A/P), 2.5 for each group and compared by ANOVA followed by a ust 17, !L/M), and -8.0 (V/D) mm from the top of the skull for Student-Newman-Keuls multiple comparison test using Implantation into the striatum and-4.8 (A/P), 1.5 (L/M), Sigmastat (Jandel Scientific, San Rafael, CA, U.S.A.). A C.J.
-7.8 (V/D) for midbrain probes (Paxinos and Watson, value of p < 0.05 was accepted as indicating a significant !. Gal-1986) . All coordinates were verified by prior dye injection difference between groups. )PAC, For the midbrain implantations, these coordinates HVA, _i_ placed the tip of the microdialysis probe at the dorsal surIn vitro release studies buffer; _: face of the substantia nigra zona compacta. A small maAll superfusion experiments were conducted using slices oxin. i;_*chine screw was also partially inserted into the skull to serve of rat striata preloaded with foci T r istration of MDMA (20 mg/kg s.c.) produced a mas2o0o r/I _-_xor-_I_T/ sive and sustained increase in extracellular concentra- group such that all three treatment groups were indis-MDMA.and 1.0 gMMOL100,907 plus MOMA,respectively, tinguishable by the end of the experiment. In contrast to the effect of MDL 100,907 on dopax 250 _m) were prepared using a Mcllwain tissue chopper mine release, the antagonist had no effect on MDMAand incubated for 10 min at 37°C in Krebs-Ringer bicarinduced changes in extracellular concentrations of the bonate buffer (KRB) containing (mM): NaCI 118, KC1 dopamine metabolites DOPAC and HVA. Basal con-4.85, CaC1 2.5, MgSO4 1.15, KH2PO 4 1.15, NaHCO3 25, centrations of DOPAC and HVA were 2,628 _+ 328 glucose 11.l,atpH 7.3. All solutions also contained 100tzM pg/32 tzl (n = 15) and 2,690 + 301 pg/32/_1 (n = 16), pargyline and were constantly bubbled with 95% 02/5%
respectively. Both metabolites declined in concentra-CO2.
[3H]Dopamine (New England Nuclear, Boston, MA, tion by >-50% after MDMA administration regardless U.S.A.; 7.5 Ci/mmol) wasaddedat 100 nMand the incubaof the presence of MDL 100,907 (Fig. 2) . tion was continued for an additional 15 min. After washing,
The effect of intrastriatal infusion of MOL 100,907 the slices were resuspended in KRB and aliquoted to 16 was duplicated using the selective 5-HT2 antagonist chambers (0.25 ml) of an SF-18 superfusion system (Branamperozide. Infusion of I _M amperozide produced a del, Gaithersburg, MD, U.S.A.). Slices were washed in the chambers for an additional 30 min at 0.5 mi/rain before reduction in MDMA-stimulated dopamine effiux alcollect,ion was initiated. One-half of the chambers served as most identical to that observed at the same concentracontrols and the other half were continuously exposed to tion of MDL 100,907 (Fig. 3) . Amperozide was witheither MDL 100,907 or amperozide at 1.0_M. The effluent out effect on the MDMA-induced changes in DOPAC from the slices was collected directly in scintillation vials in and HVA (data not shown). 4-min fractions. Release was stimulated by a 4-min expo-A second potential site ofserotonergic regulation of sure to MDMA at increasing concentrations. Slices were the striatal dopamine system is at the level of the midpulsed with MDMA during fractions 3, 7, 11, 15, and 21.
brain dopaminergic nuclei. To determine if blockade Fractional release was calculated for each 4-min period and the release above baseline during each stimulation (S__s)was of 5-HT 2 receptors in this region would have any et; plotted for control and antagonist treated slices as a funcfeet on MDMA-induced increases in striatal dopation of the MDMAconcentration, mine release, rats were implanted with microdialysis :1, Drugs probes in both the midbrain and ipsilateral striatum.
The location of the midbrain probe was selected to fluorophenylethyl)]-4-piperidinemethanol] was synthesized position the dialysis membrane immediately dorsal to at the Marion Merrell Dow Research Institute (Cincinnati, the substantia nigra zona compacta without physi-OH, U.S.A.). Amperozide-HC1 was the generous gift of cally disturbing the nucleus. This probe was then used Kabi Pharmacia Therapeutics AB (Helsingborg, Sweden).
to infuse MDL 100,907 into the cell body region MDMA-HC1 was provided by the National Institute on while extracellular concentrations of dopamine and Drag Abuse (Washington, D.C., U.S.A.). All other chemiits metabolites were determined simultaneously in the cals were purchased from Sigma Chemical Co. (St. Louis, MO,U.S.A.).
striatum. Figure 4 illustrates the results from these experiments. The effect of MDMA (20 mg/kg s.c.) on RESULTS dopamine efflux was very similar to that observed in Figure 1 shows the results of experiments in which the first series of experiments (Figs. I and 3) with an MDL 100,907 was infused directly into the striatum _20-fold increase in extracellular transmitter con- Fig. 6 ). In the presence of ntra_tM) into the region of the brain containing the dopa-TTX, MDMA (20 mg/kg s.c.) increased transmitter withminergic cell bodies had no effect on MDMA-stimu-PAC lated dopamine release in the striatum. .) on MDMA (Fig. 5 ).
probes were implanted in both the midbrain and stratum. The ed in A final series of experiments was undertaken to deantagonist was infusecl directly into the midbrain viathe probe.
Other experimental conditions are the same as those described in .h an termine ifthe 5-HT 2receptors of interest were located the legend to Fig. 1 . The MDMA control curve is the mean of four conon the dopaminergic terminals of the striatum. If rats, whereas n = 3 for the MDL 100,907 plus MDMA curve. J, (Axelsson et al., 1991 1992; Brodkin et al., 1993 ). In addition, MDL 100,907 does not completely prevent dopamine synthesis. We have previously demonstrated that MDL efflux to ,-_1,000% of the original baseline regardless 100,907 has no effect on basal dopamine synthesis of the presence of MDL 100,907. Infusion of TTX also produced a rapid decline in striatal concentrations of DOPAC and HVA, which decreased further ,6o after the administration of MDMA. Coinfusion of ! -o-MOM^ (20) · 1.0 uM TTX shown).MDL 100.907 had no effect on these changes (not
The results of this study indicate that 5-HT 2 recep-,. 1990; Mengod et al., 1990) . In contrast, both apcontrary to the results observed in vivo. Therefore, it /IDL proaches indicate little or no expression of 5-HT 2 reappears unlikely that the effect of either MDL ning ceptors in the substantia nigra. There is, however, elec-100,907 or amperozide on MDMA-induced dopazntitrophysiological evidence suggesting 5-HT 2 receptors mine release described in the present study can be hich may play a role in the regulation ofdopaminergic acattributed to interference with the interaction of can tivity at the cell body level (Nedergaard et al., 1988) . It MDMA and the dopamine uptake carder. chatherefore appeared reasonable to consider the possibilRecently, Nash and Brodkin ( 1991 a) examined the ity that a functionally significant number of 5-HT2 effects of a number of pharmacological agents on the aced receptors might exist in this region and that these rerelease of dopamine produced by intrastriatal infu-:ions , _'ptors may be responsible for the effect of 5-HT 2 sion of MDMA. These authors reported that the sysestireceptor blockade on MDMA-induced dopamine retemic administration of the dopamine uptake t atlease, blockersmazindolor GBR 12909attenuatedthe do-:, in
The results from the intranigral infusion experipamine effiux elicited by infusion of 10 tzM MDMA emments address two issues. The failure of 5-HT: recepthrough the dialysis probe. The 5-HT uptake inhibithis tot blockade in the midbrain to alter MDMA-induced tot fluoxetine also caused a small but significant renfudopamine effiux in the striatum indicates that it is duction in the release produced by MDMA. In con-0.1 unlikely that the receptors in the cell body region are trast to the result reported in the present study, systhe responsible for the attenuation of MDMA-induced temic administration of the 5-HT 2 antagonist due ?lease observed with systemic administration of 5-ketanserin produced only a small attenuation of rether _iT: antagonists. The results also indicate that diffulease, which did not reach statistical significance. lted sion of MDL 100,907 within the brain during dialysis Beyond transposing the routes of agonist and antagosuris restricted and probably limited to the immediate nist administration, there are a number of important 2vith vicinity of the probe, differences between these two studies. The most imibits Although the concentrations of the 5-HT 2 antagoportant of these variables may be the concentration of :ock nists achieved in the brain during infusion were quite MDMA in the striatum and the duration of drug exal., low, the direct application of the antagonist to striatal posure. Our hypothesis regarding the mechanism by _DL tissue could result in nonreceptor-mediated effects, which 5-HT 2antagonists inhibit MDMA-induced reThe reported activity of amperozide as a dopamine lease is based upon the concept that the carrier-depen-;yn-DL _ :-take inhibitor (Eriksson and Christensson, 1990) dent release produced by MDMA is dependent on the esis suggests the possibility that interference with the docontinuous availability of a small pool of newly synpamine carder could underlie the inhibition of thesized transmitter. By interfering with the stimula-MDMA-induced release observed here. Interference tion of synthesis, 5-HT 2 receptor antagonists effecwith the dopamine uptake carder has been shown to tively eliminate the pool of transmitter available for block MDMA-induced dopamine release both in virelease (Schmidt et al., 1991) . This is consistent with x tro (Schmidt et al.. 1987) and in vivo (Nash and Brodthe ability of the tyrosine hydroxylase inhibitor ax kin, 199 la). Indeed. direct intrastriatal infusions of methyl-p-tyrosine to reduce MDMA-induced dopa-_, high concentrations ofamperozide have been shown mine release by >70% when administered only 20 to block amphetamine-induced dopamine release by min before MDMA (Schmidt et al., 1992) , although innibition of the dopamine uptake carrier. However, studies have shown this treatment reduces tissue concentrations of amperozide of >_25 sim were restores ofstriatal dopamine by <20% at I h (Soares-da quired to produce this effect (Yamamoto and Silva and Garrett, 1990 ). In the study by Nash and Meltzer, 1992). These concentrations ofamperozide Brodkin (1991a), intrastriatal infusions of 10 uM also produced a significant increase in the basal effiux MDMA produced a fivefold increase in dopamine reof striatal dopamine. The concentration of amperolease, which lasted 30 min. Systemic administration zide (1.0 t_M) used in the present study is less than the of MDMA at a dose of 20 mg/kg has been reported to no-effect concentration used by Yamamoto and result in a brain drug concentration of 165 3tM Meltzer (1992)and was without effect on basal effiux. (Zaczek et al., 1989) and in the present study inTo address this question further, we examined the creased striatal dopamine concentrations above base-I-ineffect of both amperozide and MDL 100,907 on the line for > 180 min with a peak release of 18-to 20-fold _07.
MDMA-induced effiux of [3H]dopamine from superabove baseline. It therefore appears reasonable that ,wn fused striatal slices. Both antagonists were tested at the small amount of release produced by direct infu-= 4) 1.0 tzM, the highest concentration perfused through sion of MDMA would not require the same degree of MA the probes, for their ability to shift the concentrationsupport from the biosynthetic machinery of the dopa- ceptor blockade might be expected to have little effect sponsible for this effect of TTX is not clear, one poon small increases in dopamine release. Indeed, 5-tential explanation is that the reduction in depolariza-HT2 antagonists are more effective at inhibiting the tion-induced Ca 2+ influx slows the rate of dopamine behavioral effects of high doses of MDMA compared synthesis. Tyrosine hydroxylase is normally activated with low doses (J. H. Kehne, personal communicaby a Ca2+/calmodulin-dependent phosphorylation, tion). Based on these considerations, the failure ofkewhich is subject to changes in cell firing and Ca 2+ intanserin to inhibit the release ofdopamine produced flux (Roth et al., 19871 . A reduction in the rate of by the infusion of low concentrations of MDMA is terminal depolarization could decrease the level of not at variance with our conclusion that 5-HT 2 recepdopamine synthesis and thereby affect the pool of tor antagonists interfere with MDMA-stimulated dotransmitter available for cartier-dependent release. pamine release by blocking the action of 5-HT at reSuch an effect of TTX on synthesis could essentially ceptors in the striatum, mask any effect of 5-HT2 receptor blockade on The final series of experiments included in the pres-MDMA-induced release. Further work will be reent study sought to determine if the location of the quired to eliminate this possibility. 5-HT2 receptors of interest was pre-or postsynaptic
In conclusion, the results indicate that the activawith respect to the dopaminergic terminals. This was tion of 5-HT2 receptors on nondopaminergic eleexamined by the coinfusion of TTX into the striatum ments of the striatum augments the dopamine release with MDL 100,907. By blocking voltage-dependent produced by high doses of the amphetamine analogue sodium channels, TTX interferes with axonal con-MDMA. Further studies are required to determine duction and interrupts electrical activity in the tissue the precise neuronal location of these receptors and (Narahashi, 19741. MDMA-induced transmitter rethe mechanism through which they influence dopamilease is nonexocytotic and therefore occurs in the abnergic function. However, the nondopaminergic locasence of cell firing. Thus, in the presence of TTX and tion of these receptors suggests that striatal 5-HT 2 re-MDMA, 5-HT release and 5-HT 2 receptor activation ceptors could mediate both dopamine-dependent and will still occur. If the 5-HT2 receptors are located on independent actions of MDL 100,907 and related the dopaminergic terminal, the effect of 5-HT 2 recepagents on basal ganglia function. tor stimulation on MDMA-induced dopamine release should be unaffected by the presence of TTX. If they are located elsewhere in the striatum, it is likely
